Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis

Diabetes, Obesity & Metabolism
Rong-Rong FanGang Xu

Abstract

Glucagon-like peptide-1 (GLP-1) stimulates beta-cell proliferation and enhances beta-cell survival, whereas oligomerization of human islet amyloid polypeptide (hIAPP) may induce beta-cell apoptosis and reduce beta-cell mass. Type 2 diabetes is associated with increased expression of IAPP. As GLP-1-based therapy is currently developed as a novel antidiabetic therapy, we examined the potential protective action of the GLP-1 receptor agonist exendin-4 on hIAPP-induced beta-cell apoptosis. The study was performed in clonal insulinoma (INS-1E) cells. Both method of transcriptional and translational and sulphorhodamine B (SRB) assays were used to evaluate cell viability and cell mass. Western blot analysis was applied to detect protein expression. Transfection of constitutively active protein kinase B (PKB/AKT) was performed to examine the role of AKT. Mitochondrial biogenesis was quantified by mitogreen staining and RT-PCR. First, we confirmed that hIAPP induced cell apoptosis and growth inhibition in INS-1E cells. These effects were partially protected by exendin-4 in association with partial recovery of the hIAPP-mediated AKT inhibition. Furthermore, AKT constitutive activation attenuated hIAPP-induced apoptosis, whereas PI3K/AKT ...Continue Reading

References

Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B Thorens
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G J CooperK B Reid
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·E J de KoningJ S Verbeek
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·J JansonP C Butler
Aug 10, 2000·The New England Journal of Medicine·J W HöppenerC J Lips
Sep 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ottavio V VitoloMichael Shelanski
Jan 19, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M Sörhede Winzell, B Ahrén
Jan 13, 2006·Diabetes Research and Clinical Practice·Gang XuSusan Bonner-Weir
Nov 7, 2006·Cell Metabolism·Ronald C Wek, Tracy G Anthony
Oct 4, 2007·American Journal of Physiology. Endocrinology and Metabolism·Chang-Jiang HuangPeter C Butler
Mar 4, 2008·Endocrine Reviews·Leena HaatajaPeter C Butler
Apr 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maarten F M EngelJo W M Höppener
Oct 11, 2008·The Journal of Clinical Investigation·Samira AlliouacheneMario Pende
Dec 17, 2008·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·D TewsJ Eckel

❮ Previous
Next ❯

Citations

Feb 22, 2012·Brain : a Journal of Neurology·Iciar Aviles-OlmosThomas Foltynie
Jun 4, 2013·The Journal of Clinical Investigation·Iciar Aviles-OlmosThomas Foltynie
Apr 23, 2014·Protein Expression and Purification·Iga KosickaNiels Chr Nielsen
Jan 23, 2013·Journal of Drug Targeting·Jie ZhengYu Liu
Jan 5, 2011·Toxicon : Official Journal of the International Society on Toxinology·Brian L Furman
Feb 18, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Thomas Foltynie, Iciar Aviles-Olmos
Jul 26, 2011·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Eun Mi Choi
Mar 10, 2017·Progress in Neurobiology·Yun Zhang, Weihong Song
Feb 6, 2017·International Journal of Cardiology·Kyung Hye LeeWeon Kim
Aug 2, 2018·CNS Drugs·Dilan Athauda, Thomas Foltynie
Nov 13, 2018·Journal of Cellular Physiology·Habib YaribeygiAmirhossein Sahebkar
Aug 13, 2014·Nature Reviews. Endocrinology·Joana Osório
Mar 1, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yaohui NieGang Xu
Sep 11, 2019·Protein Engineering, Design & Selection : PEDS·Meghan F HoganSteven E Kahn
Nov 1, 2018·Current Medicinal Chemistry·Xinwang YangEng-Ang Ling
Sep 30, 2014·Journal of Cardiovascular Pharmacology·Amy C KellerJane E B Reusch
Feb 26, 2019·Movement Disorders Clinical Practice·Tom Foltynie, Dilan Athauda
Apr 26, 2020·Journal of Parkinson's Disease·Julia L Y CheongAlastair J Noyce
Aug 31, 2018·Brain : a Journal of Neurology·Eridan Rocha-FerreiraAhad A Rahim
Dec 16, 2020·Archives of Endocrinology and Metabolism·Valeria Bahdur Chueire, Elza Muscelli
Jan 21, 2021·Frontiers in Cell and Developmental Biology·Jannik PrasuhnKishore R Kumar
Jan 19, 2021·Journal of Diabetes Research·Nicholas EschEmilyn U Alejandro
Feb 27, 2021·Molecular Medicine·Theodora NtetsikaIoanna Markaki
Jun 3, 2021·International Journal of Molecular Sciences·Safia CostesMagalie A Ravier
Oct 13, 2021·Journal of Cellular Physiology·Carine MarmentiniMirian A Kurauti
Mar 20, 2018·Neurochemistry International·Navneet Ammal Kaidery, Bobby Thomas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis